We've teamed up with health insurance and policy experts to model how insurance plans could be designed if they couldn’t rely on OOP costs for prescribed treatments. So far, our findings suggest it’s possible to eliminate OOP costs while preserving payers’ ability to negotiate with providers and drug companies.
Feel free to reach out with questions, concerns, or comments.
Contact us